Views

WHITE PAPER – Biotech and Breakthroughs in Immuno-Oncology

WHITE PAPER – Biotech and Breakthroughs in Immuno-Oncology

Key Points

  • Paradigm-shift in disease management with the approval of immuno-oncology agents, namely, checkpoint inhibitors, created a major shift in how patients with cancers are treated.
  • The significant clinical impact of checkpoint inhibitors led to what some have seen as a goldrush, others as a bubble, toward clinical development of immunotherapies.
  • Immuno-oncology agents have not by and large cured most patients in most cancers, hence new immunotherapeutic agents and combinations are needed.
  • Over the past 5 years, much of the BioPharma industry’s focus has been on expanding the range of immuno-oncology agents and combinations.

Complete the information below to download your free copy of the White Paper

For further information about our range of services

Contact Us

Share this

Related Articles

The US Forecaster’s Check List for Japan: A World of Difference
24 September 2021
The US Forecaster’s Check List for Japan: A World of Difference

The US Forecaster’s Check List for Japan: A World of Difference

Expanding the valuation of a biopharmaceutical asset to Japan requires a new mindset in nearly every input of forecasting, with many pitfalls. Doug Willson, Senior Vice President, Cello Health Advantage and Tiffany Ahlers, Chief Commercial Officer, Mycovia Pharmaceuticals Inc., share a checklist to improve the rigor and validity of product forecasts for Japan.

Unmet Needs Analysis: Cancer Patients and Caregivers
24 September 2021
Unmet Needs Analysis: Cancer Patients and Caregivers

Using organic and unfiltered social media data, Cello Health is proud to share with you the first in a series of reports aimed at centralizing and amplifying the authentic patient experience.

April 2021 Event Summary Available to Download
25 June 2021
April 2021 Event Summary Available to Download

Embedding patient journeys into clinical and commercial planning, for more focused decisions and improved patient outcomes.

Happy MedComms Day 2021
08 June 2021
Happy MedComms Day 2021

Happy MedComms Day 2021 from Cello Health’s Global Communications Team

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us